Mepsevii OverviewSly syndrome, also called mucopolysaccharidosis type VII (MPS-VII), is an autosomal recessive lysosomal storage disease caused by a deficiency of the enzyme β-glucuronidase. This enzyme is responsible for breaking down large sugar molecules called glycosaminoglycans (AKA GAGs, or mucopolysaccharides). The inability to break down GAGs leads to a buildup in many tissues and organs of the body. The severity of the disease can vary widely. Contents 1 Signs and symptoms...
Read more Mepsevii Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sly_syndrome
Recent Mepsevii Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 10mg/5ml
NDC Database Records for Mepsevii: (1 result)Sorted by National Drug Code
- 69794-001 Mepsevii 2 mg/ml Intravenous Injection by Ultragenyx Pharmaceutical Inc.